Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;26(5):433-441.
doi: 10.1097/MCC.0000000000000755.

Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic

Rafael Cantón  1   2 , Desirèe Gijón  1   2 , Patricia Ruiz-Garbajosa  1   2
Affiliations
Review

Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic

Rafael Cantón et al. Curr Opin Crit Care. 2020 Oct.

Abstract

Purpose of review: To describe current antimicrobial resistance in ESKAPE Gram-negative microorganisms and their situation in the ICUs, the implication of the so-called high-risk clones (HiRCs) involved in the spread of antimicrobial resistance as well as relevance of the COVID-19 pandemic in the potential increase of resistance.

Recent findings: Extended-spectrum and carbapenemase producing Enterobacterales and multidrug and extensive drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii have increased worldwide. Sequence type (ST)131 Escherichia coli, ST258, ST11, ST10, ST147 and ST307 Klebsiella pneumoniae, ST111, ST175, ST235 and ST244 P. aeruginosa HiRCs are responsible for this increase in the ICUs, and some of them are implicated in the emergence of resistance mechanisms affecting new antimicrobials. A similar situation can be found with European clonal complex 1 and clonal complex 2 of A. baumannii. The high use of antimicrobials during the COVID-19 pandemic, particularly in ICUs, might have a negative influence in future trends of antimicrobial resistance.

Summary: The increase of antimicrobial resistance in ICUs is mainly due to the spread of HiRCs and is exemplified with the ESKAPE Gram-negative microorganisms. The COVID-19 pandemic might have a negative impact in the increase of antimicrobial resistance and should be monitored through specific surveillance studies in ICUs.

PubMed Disclaimer

References

    1. Cantón R, Ruiz-Garbajosa P. Co-resistance: an opportunity for the bacteria and resistance genes. Curr Opin Pharmacol 2011; 11:477485.
    1. Rawson TM, Ming D, Ahmad R, et al. Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol 2020; 2:12.
    1. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268281.
    1. Strich JR, Kadri SS. Difficult-to-treat antibiotic-resistant Gram-negative pathogens in the intensive care unit: epidemiology, outcomes and treatment. Semin Respir Crit Care Med 2019; 40:419434.
    1. Kadri SS, Lai YLE, Ricotta EE, et al. External validation of difficult-to-treat resistance prevalence and mortality risk in Gram-negative bloodstream infection using electronic health record data from 140 US hospitals. Open Forum Infect Dis 2019; 6:ofz110.

Publication types

Substances